Surgery News and Research

RSS

Roche’s new breast cancer drug Pertuzumab up for FDA review

U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.

7 Feb 2012

New guidelines for travellers to avoid DVT on long flights

New guidelines for travellers have been issued. Experts warn that those with a higher risk of serious blood clots who opt for the window seat on flights longer than four hours are potentially putting themselves in danger. People who should be most concerned are those who have recently had surgery, cancer patients, those with limited mobility, the severely obese, and travellers over 70. However, healthy women on the pill and those who are pregnant should also be careful, according to the guidelines by the American College of Chest Physicians.

7 Feb 2012

High soft drink consumption associated with asthma and COPD

A new study published in the journal Respirology reveals that a high level of soft drink consumption is associated with asthma and/or chronic obstructive pulmonary disease (COPD).

7 Feb 2012

World’s first 3D printed jaw transplant

In a medical breakthrough, doctors and bio-engineers have collaborated

7 Feb 2012

Spectros 2011 sales revenue increases 69%

Spectros announced today that year-over-year sales revenue rose 69% in 2011. This is the fourth year in a row for double-digit revenue growth for Spectros since the current T-Stat Oximeter was launched in 2008.

7 Feb 2012

NYU Langone experts to present at American Academy of Orthopaedic Surgeons annual meeting

Experts from the Department of Orthopaedic Surgery at NYU Langone Medical Center will present their latest research and clinical findings on diseases of the muscle, tendon, bone and joint at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS), February 7-11 in San Francisco, California.

7 Feb 2012

Three new targeted drugs can lead to fatal cancer complications

Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients.

7 Feb 2012

Study may explain why women have higher rate of ACL injuries than men

Much orthopaedic research has been devoted to determining why women are far more susceptible to knee ligament injuries than men. According to a new study, the answer may lie in geometry - the length and shape of a patient's knee bone - more than gender.

7 Feb 2012

Fogarty Institute's Advanced Endovascular Training Fellowship to begin on July 1

The Fogarty Institute for Innovation announced today that it has launched its Advanced Endovascular Training Fellowship. This unique, year-long clinical training program for postgraduate physicians, which begins July 1, 2012, will provide Fellows with broad exposure to all aspects of endovascular patient care, with an emphasis on interventional training.

7 Feb 2012

Epilepsy surgery improves QOL and long-term seizure control

While epilepsy surgery is a safe and effective intervention for seizure control, medical therapy remains the more prominent treatment option for those with epilepsy. However, a new 26-year study reveals that following epilepsy surgery, nearly half of participants were free of disabling seizures and 80% reported better quality of life than before surgery.

7 Feb 2012

Researchers reveal how molecular imaging can solve breast cancer mysteries

In two new studies featured in the February issue of the Journal of Nuclear Medicine, researchers are revealing how molecular imaging can be used to solve mysteries about difficult cases of breast cancer.

7 Feb 2012

New ACCP guidelines address DVT/PE risk factors for long-distance travel

New evidence-based guidelines from the American College of Chest Physicians (ACCP) address the many risk factors for developing a deep vein thrombosis (DVT), or blood clot, as the result of long-distance travel.

7 Feb 2012

Wake Forest Baptist researchers create emergency general surgery registry

Researchers at Wake Forest Baptist Medical Center in Winston-Salem, NC, have successfully created and implemented an emergency general surgery registry (EGSR) that will advance the science of acute surgical care by allowing surgeons to track and improve surgical patient outcomes, create performance metrics, conduct valid research and ensure quality care for all emergency general surgery (EGS) patients.

7 Feb 2012

AJRR selects Remedy Informatics to build national hip and knee replacement registry

The American Joint Replacement Registry (AJRR) has selected Remedy Informatics, the leading provider of registries for Life Science, to build a registry to collect data on all primary and revision total joint replacement procedures in the United States. Representatives from AJRR and Remedy Informatics will unveil the new registry at the American Association of Orthopaedic Surgeons (AAOS) Annual Meeting in San Francisco, Feb. 7 – Feb. 11.

7 Feb 2012

Researchers derive vessel-forming stem cells from amniotic fluid

Researchers at Rice University and Texas Children's Hospital have turned stem cells from amniotic fluid into cells that form blood vessels. Their success offers hope that such stem cells may be used to grow tissue patches to repair infant hearts.

7 Feb 2012

Preliminary results from Remedy Pharmaceuticals' RP-1127 Phase 2 trial on stroke

Each year, over 700,000 people in the United States suffer a stroke. For most, medical science can do very little. Some will die; a number will suffer debilitating aftereffects. Now, preliminary results of a Phase 2 clinical trial using Remedy Pharmaceuticals' new drug, RP-1127, presented at the 2012 International Stroke Conference in New Orleans on February 2, offer hope to many of these patients.

6 Feb 2012

Successful six organ transplants in 9 year old

A 9 year old girl from Maine is making recovery days after surgeons transplanted six of her organs in a groundbreaking medical procedure.

6 Feb 2012

Audax Group acquires Advanced Dermatology and Cosmetic Surgery

Audax Group announced it has completed the acquisition of Advanced Dermatology and Cosmetic Surgery. Headquartered in Maitland, Florida, ADCS is a dermatology-focused physician practice management company, with 53 company-affiliated dermatology clinics in Florida and Ohio providing clinical, cosmetic, and pathology services.

6 Feb 2012

TeDan Surgical launches Phantom Series MIS Anterior Hip Retractor System

TeDan Surgical Innovations, industry leader in surgical access instrumentation, announces the launch of the Phantom Series MIS Anterior Hip Retractor System. TeDan Surgical's revolutionary hip retractor utilizes a system of adjustable surgical arms with attachable retractors, enabling surgeons to perform the entire procedure without a fracture table or a surgical assistant.

6 Feb 2012

Russian neurosurgical institute acquires Leksell Gamma Knife Perfexion system

Russia's first Leksell Gamma Knife Perfexion system has found a home at the renowned N.N. Burdenko Neurosurgical Institute, just a five-minute car ride from Moscow's Red Square.

From Elekta 6 Feb 2012